Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on October 29, 2004, to report its financial results for the third quarter of 2004. The filing primarily serves to furnish the press release announcing these results, along with supplemental information available on the company's website. This provides investors with official data regarding the company's operational and financial performance during the period. Investors should review the furnished press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) for detailed insights into BMY's third-quarter performance, including key financial metrics, operational achievements, and any forward-looking statements or guidance. The 8-K itself acts as a notification and access point to these crucial performance indicators.
Key Highlights
- 1Bristol-Myers Squibb (BMY) announced its third-quarter 2004 financial results via an 8-K filing on October 29, 2004.
- 2The filing includes a press release detailing the Q3 2004 financial performance.
- 3Supplemental financial information is also provided and available on the company's website.
- 4This 8-K serves as the official disclosure mechanism for BMY's Q3 2004 earnings.
- 5Investors are directed to Exhibits 99.1 (press release) and 99.2 (supplemental information) for detailed results.